Each week, TransparentShare presents three stocks with a current buy recommendation that are still trading significantly below their yearly highs. Their valuation and the current price lag make them interesting candidates for a potential recovery. This week's "Undervalued Stocks of the Week" series focuses on companies from the digital marketplace, technology, and pharmaceutical sectors.
3 undervalued stocks of week 35, 2026
TransparentShare currently analyzes 1,340 stocks worldwide. Of these, 69 stocks meet the criteria for a buy recommendation and are simultaneously trading below their 52-week high. The valuation is as of August 21, 2026.
Auto Trader Group, Alphabet, and Hikma Pharmaceuticals all received a buy recommendation this week, despite trading significantly below their respective 52-week highs. All three companies exhibit solid metrics in the TransparentShare valuation, making them attractive to investors.
- Auto Trader Group with a distance of 34.55 percent at the year's highest price
- alphabet with a distance of 14.21 percent at the year's highest price
- Hikma Pharmaceuticals with a distance of 11.57 percent at the year's highest price
Analyze all 69 buy recommendations now
Free registration. Try it free for 21 days. No subscription. No payment details required. Start instantly.
Auto Trader Group – A powerful digital car marketplace
Auto Trader Group is a British technology company that operates one of the largest digital marketplaces for buying and selling vehicles in the UK.
Auto Trader is benefiting from growing demand for online vehicle exchanges and has recently been able to increase its revenue while further expanding its digital services for dealers and private sellers.
Particularly striking is the very high profit margin of 62.09 percent, which indicates an exceptionally profitable business model in the field of digital marketplaces.
Check current Auto Trader Group rating
Alphabet – a technology giant with a solid foundation
Alphabet is the parent company of Google and one of the world's largest technology companies, offering search engines, advertising technology, cloud services and other digital products.
Alphabet is currently in the spotlight because the company has significantly increased its investments in artificial intelligence, i.e., computer-based systems that mimic human thinking, and is benefiting from this primarily in its cloud business.
Particularly positive is the high return on equity of 31.83 percent, which shows how efficiently the company uses the capital invested by shareholders.
Hikma Pharmaceuticals – a pharmaceutical company with growth potential
Hikma Pharmaceuticals is an international pharmaceutical company based in London that develops and distributes generic (low-priced copycat) and branded medicines in over 50 countries.
Hikma recently attracted attention with an expected profit growth of 8.70 percent and a strong market reaction to its latest quarterly figures, indicating solid operational performance.
Of particular note is the profit margin of 18.36 percent, which indicates a profitable business model for a pharmaceutical company in a highly competitive market.
Check current Hikma Pharmaceuticals rating
Current buy recommendations
TransparentShare currently recommends 69 shares to buy. The evaluation is current as of August 21, 2026. All ratings are based on an objective analysis of 1,340 stocks worldwide.
- 9 stocks from Germany
- 9 more stocks from Europe
- 30 stocks from the USA
- 21 stocks from Asia and other international markets
If you want to know which stocks are currently rated particularly positively, you can view all buy recommendations directly in the app.
Register now for the free trial. Use the coupon code. UA21 You can use TransparentShare for 21 days free of charge, without a subscription and without providing payment details.
View all 69 buying recommendations
Try it free for 21 days. No subscription. No payment details required. Start instantly.
This is in the current newsletter – Underrated Stocks Week 35 2026
If you don't want to miss any more newsletters, you can subscribe for free now. Register here. In the current newsletter you will find further content about current buy recommendations and exciting stock analyses.
- Underrated stocks of week 34: Auto Trader, Alphabet and Hikma Pharmaceuticals compared
- Einhell Germany: Solid delivery despite challenging market environment in the first half of 2026
- What you should check before every long-term stock investment
- BMW converts preferred shares into common shares
Undervalued stocks of the previous weeks
- 3 undervalued stocks Week 34 2026
- 3 undervalued stocks Week 33 2026
- 3 undervalued stocks Week 32 2026
- 3 undervalued stocks Week 31 2026
Frequently Asked Questions about Undervalued Stocks Week 35 2026
What does it mean when a stock is trading below its yearly high?
The 52-week high is the highest price a stock has reached in the past twelve months. If a stock is trading below this high, it means it is cheaper than at its previous peak. This alone says nothing about the quality of the company, but in combination with a positive valuation, it can be an interesting starting point for further analysis.
How does TransparentShare select the three stocks of the week?
TransparentShare evaluates 1,340 stocks worldwide daily using objective metrics such as return on equity, profit margin, and expected earnings growth. From all stocks with a current buy recommendation, the TransparentShare editorial team highlights three that also show a significant margin below their 52-week high.
Are the presented stocks a buy recommendation for me?
Although the presented stocks carry a buy recommendation in the TransparentShare rating system, this does not replace individual advice. Every investor should consider a stock in the context of their own financial situation, investment horizon, and risk tolerance before making a decision.
Risk warning: The assessments provided by TransparentShare are for informational purposes only and do not replace individual advice. All information is provided without guarantee.
This article was initially created with AI support and reviewed and approved by the TransparentShare editorial team before publication.
